2,285
|
19578 |
2-Heptyl-3-hydroxy-4-quinolone, PQS
|
|
increases_expression of
|
rsmZ
|
|
19579 |
2-Heptyl-4-quinolone, HHQ
|
NOT |
increases_expression of
|
rsmZ
|
|
|
20738404
|
Pseudomonas aeruginosa diseases
|
2,555
|
23823 |
retS
|
|
decreases_expression of
|
vgrG1a
|
|
23831 |
ladS
|
|
decreases_activity of
|
retS
|
if ladS is overexpressed
|
23836 |
ladS
|
|
increases_expression of
|
T6SS-HSI-1 complex
|
if ladS is overexpressed
|
|
21325275
|
Pseudomonas aeruginosa diseases
|
2,565
|
24052 |
retS
|
|
increases_expression of
|
T3SS complex
|
|
24053 |
retS
|
|
decreases_activity of
|
biofilm formation
|
|
24054 |
retS
|
|
decreases_expression of
|
T6SS-HSI-1 complex
|
|
24055 |
ladS
|
|
increases_expression of
|
T6SS-HSI-1 complex
|
|
24056 |
ladS
|
|
decreases_expression of
|
T3SS complex
|
|
24057 |
ladS
|
|
increases_activity of
|
biofilm formation
|
|
28406 |
rsmA
|
|
decreases_expression of
|
T6SS-HSI-1 complex
|
DNA microarray approach
|
|
20511495
|
Pseudomonas aeruginosa diseases
|
2,592
|
24461 |
retS
|
|
decreases_activity of
|
gacS
|
|
24462 |
gacS
|
|
increases_activity of
|
gacA
|
|
24469 |
gacA
|
|
increases_expression of
|
rsmY
|
|
24470 |
gacA
|
|
increases_expression of
|
rsmZ
|
|
24471 |
rsmY
|
|
affects_activity of
|
rsmA
|
|
24474 |
rsmZ
|
|
affects_activity of
|
rsmA
|
|
24475 |
rsmA
|
|
decreases_quantity of
|
pel-exopolysaccharide
|
|
24479 |
rsmA
|
|
decreases_expression of
|
T6SS-HSI-1 complex
|
|
24480 |
rsmA
|
|
increases_expression of
|
T3SS complex
|
|
24560 |
ladS
|
|
increases_expression of
|
rsmY
|
|
24561 |
ladS
|
|
increases_expression of
|
rsmZ
|
|
26441 |
retS
|
|
interacts (colocalizes) with
|
gacS
|
|
30043 |
rsmA
|
|
decreases_quantity of
|
psl-exopolysaccharide
|
|
|
21955777
|
Pseudomonas aeruginosa diseases
|
2,854
|
26279 |
gacS
|
|
affects_activity of
|
P. aeruginosa infection, acute
|
|
26280 |
gacA
|
|
affects_activity of
|
P. aeruginosa infection, acute
|
|
26281 |
retS
|
|
affects_activity of
|
P. aeruginosa infection, acute
|
|
33965 |
gacS
|
|
affects_activity of
|
P. aeruginosa infection, chronic
|
|
33966 |
gacA
|
|
affects_activity of
|
P. aeruginosa infection, chronic
|
|
|
21515773
|
Pseudomonas aeruginosa diseases
|
2,879
|
26503 |
retS
|
|
increases_expression of
|
T3SS complex
|
|
26513 |
hptB
|
|
affects_expression of
|
rsmY
|
|
26539 |
hptB
|
NOT |
affects_expression of
|
rsmZ
|
|
26562 |
retS
|
|
decreases_expression of
|
rsmY
|
|
26563 |
retS
|
|
decreases_expression of
|
rsmZ
|
|
|
20398205
|
Pseudomonas aeruginosa diseases
|
2,880
|
26504 |
ladS
|
|
increases_expression of
|
rsmZ
|
|
26506 |
retS
|
|
decreases_expression of
|
rsmZ
|
|
|
20398205
|
Pseudomonas aeruginosa diseases
|
2,892
|
26573 |
gacS
|
|
increases_activity of
|
gacA
|
|
26575 |
gacS
|
|
increases_phosphorylation of
|
gacA
|
|
26576 |
gacA
|
|
increases_expression of
|
rsmY
|
|
26577 |
gacA
|
|
increases_expression of
|
rsmZ
|
|
26578 |
rsmZ
|
|
affects_activity of
|
rsmA
|
|
26579 |
rsmY
|
|
affects_activity of
|
rsmA
|
|
26580 |
mvaT
|
|
decreases_expression of
|
rsmZ
|
|
26582 |
mvaT
|
NOT |
affects_expression of
|
rsmY
|
|
26583 |
mvaU
|
|
decreases_expression of
|
rsmZ
|
|
26584 |
mvaU
|
NOT |
affects_expression of
|
rsmY
|
|
|
19602144
|
Pseudomonas aeruginosa diseases
|
2,894
|
26585 |
hfq
|
|
interacts (colocalizes) with
|
rsmY
|
|
26587 |
hfq
|
|
affects_quantity of
|
rsmY
|
|
26588 |
hfq
|
NOT |
interacts (colocalizes) with
|
rsmZ
|
|
26589 |
hfq
|
NOT |
affects_quantity of
|
rsmZ
|
|
|
19602144
|
Pseudomonas aeruginosa diseases
|
3,113
|
28613 |
gacA
|
|
increases_quantity of
|
flagellum
|
|
28619 |
gacA
|
|
decreases transport of
|
exoS
|
|
28620 |
gacA
|
|
decreases_activity of
|
T3SS
|
|
|
17307856
|
Pseudomonas aeruginosa diseases
|
3,206
|
29535 |
gacA
|
|
increases_expression of
|
rsmY
|
|
29536 |
gacA
|
|
increases_expression of
|
rsmZ
|
|
29537 |
rsmY
|
|
affects_activity of
|
rsmA
|
|
29539 |
rsmZ
|
|
affects_activity of
|
rsmA
|
|
29543 |
rsmA
|
|
decreases_expression of
|
T6SS-HSI-1 complex
|
|
29544 |
rsmA
|
|
increases_expression of
|
T3SS complex
|
|
29545 |
rsmA
|
|
increases_quantity of
|
type IV pilus
|
|
29546 |
rsmA
|
|
increases_activity of
|
bacterial-type flagellum-dependent cell motility
|
|
29547 |
retS
|
|
decreases_activity of
|
gacS
|
|
29548 |
ladS
|
|
increases_activity of
|
gacS
|
|
29582 |
PA3346
|
|
decreases_expression of
|
rsmY
|
|
29585 |
PA3347
|
|
decreases_expression of
|
rsmY
|
|
|
22354680
|
Pseudomonas aeruginosa diseases
|
3,231
|
30067 |
cafA
|
|
decreases_quantity of
|
rsmZ
|
|
30069 |
cafA
|
NOT |
decreases_quantity of
|
rsmY
|
|
|
21554516
|
Pseudomonas aeruginosa diseases
|
4,232
|
43237 |
retS
|
|
decreases_quantity of
|
magD
|
as shown in immunoblot analysis of strain PAO1 and PAK
|
43242 |
rsmA
|
|
affects_quantity of
|
magD
|
as shown in immunoblot analysis of strain PAO1 and PAK
|
|
23919994
|
Pseudomonas aeruginosa diseases
|
5,009
|
49416 |
rsmA
|
|
decreases_expression of
|
pvdS
|
under iron-depleted conditions
|
49420 |
rsmA
|
|
decreases_expression of
|
pchR
|
under iron-depleted conditions
|
49422 |
rsmA
|
|
decreases_quantity of
|
Pyoverdine I
|
under iron-depleted conditions
|
49424 |
rsmA
|
|
decreases_quantity of
|
Pyochelin
|
under iron-depleted conditions
|
49426 |
rsmA
|
|
decreases_quantity of
|
cdiGMP
|
under iron-depleted conditions
|
|
23796404
|
Pseudomonas aeruginosa diseases
|
6,528
|
62108 |
rsmA
|
|
decreases_quantity of
|
rahU
|
|
62109 |
rsmA
|
|
decreases_quantity of
|
algU
|
|
62116 |
rsmA
|
|
decreases_quantity of
|
mvfR
|
|
62117 |
rsmA
|
|
decreases_quantity of
|
PA1300
|
|
|
24782516
|
Pseudomonas aeruginosa diseases
|